miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia

详细信息    查看全文

• 作者：John Adams Fischer ; Stefano Rossetti ; Arani Datta ; Kevin Hasegawa Eng…
• 关键词：Core Binding Factor ; Acute myeloid leukemia ; RUNX1 ; microRNAs ; KIT ; Proliferation ; Myeloid differentiation
• 刊名：Molecular Cancer
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：14
• 期：1
• 全文大小：3,683 KB
• 参考文献：1. Lam, K, Zhang, DE (2012) RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis. Front Biosci (Landmark Ed) 17: pp. 1120-39 CrossRef
  2. Link, KA, Chou, FS, Mulloy, JC (2010) Core binding factor at the crossroads: determining the fate of the HSC. J Cell Physiol 222: pp. 50-6 CrossRef
  3. Speck, NA, Gilliland, DG (2002) Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2: pp. 502-13 CrossRef
  4. Ichikawa, M, Yoshimi, A, Nakagawa, M, Nishimoto, N, Watanabe-Okochi, N, Kurokawa, M (2013) A role for RUNX1 in hematopoiesis and myeloid leukemia. Int J Hematol 97: pp. 726-34 CrossRef
  5. Goyama, S, Mulloy, JC (2011) Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects. Int J Hematol 94: pp. 126-33 CrossRef
  6. Hatlen, MA, Wang, L, Nimer, SD (2012) AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches. Front Med 6: pp. 248-62 CrossRef
  7. Mangan, JK, Speck, NA (2011) RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making. Crit Rev Oncog 16: pp. 77-91 CrossRef
  8. Mandoli, A, Singh, AA, Jansen, PW, Wierenga, AT, Riahi, H, Franci, G, Prange, K, Saeed, S, Vellenga, E, Vermeulen, M (2014) CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia. Leukemia 28: pp. 770-8 CrossRef
  9. Shigesada, K, Sluis, B, Liu, PP (2004) Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11. Oncogene 23: pp. 4297-307 CrossRef
  10. Rossetti, S, Sacchi, N (2013) RUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis. Int J Mol Sci 14: pp. 1566-88 CrossRef
  11. Gardini, A, Cesaroni, M, Luzi, L, Okumura, AJ, Biggs, JR, Minardi, SP, Venturini, E, Zhang, DE, Pelicci, PG, Alcalay, M (2008) AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets. PLoS Genet 4: pp. e1000275 CrossRef
  12. Fazi, F, Racanicchi, S, Zardo, G, Starnes, LM, Mancini, M, Travaglini, L, Diverio, D, Ammatuna, E, Cimino, G, Lo-Coco, F (2007) Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12: pp. 457-66 CrossRef
  13. Fazi, F, Rosa, A, Fatica, A, Gelmetti, V, Marchis, ML, Nervi, C, Bozzoni, I (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123: pp. 819-31 CrossRef
  14. Ismail, N, Wang, Y, Dakhlallah, D, Moldovan, L, Agarwal, K, Batte, K, Shah, P, Wisler, J, Eubank, TD, Tridandapani, S (2013) Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 121: pp. 984-95 CrossRef
  15. Rodriguez-Ubreva, J, Ciudad, L, Oevelen, C, Parra, M, Graf, T, Ballestar, E (2014) C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages. Mol Cell Biol 34: pp. 1145-57 CrossRef
  16. Felli, N, Fontana, L, Pelosi, E, Botta, R, Bonci, D, Facchiano, F,
• 刊物主题：Cancer Research; Oncology;
• 出版者：BioMed Central
• ISSN：1476-4598

文摘

Background Core Binding Factor acute myeloid leukemia (CBF-AML) with t(8;21) RUNX1-MTG8 or inv(16) CBFB-MYH11 fusion proteins often show upregulation of wild type or mutated KIT receptor. However, also non-CBF-AML frequently displays upregulated KIT expression. In the first part of this study we show that KIT expression can be also upregulated by miR-17, a regulator of RUNX1, the gene encoding a CBF subunit. Interestingly, both CBF leukemia fusion proteins and miR-17, which targets RUNX1-3′UTR, negatively affect a common core RUNX1-miRNA mechanism that forces myeloid cells into an undifferentiated, KIT-induced, proliferating state. In the second part of this study we took advantage of the conservation of the core RUNX1-miRNA mechanism in mouse and human, to mechanistically demonstrate in a mouse myeloid cell model that increased KIT-induced proliferation is per se a mechanism sufficient to delay myeloid differentiation. Methods Human (U937) or mouse (32D) myeloid clonal lines were used, respectively, to test: 1) the effect of RUNX1-MTG8 and CBFB-MYH11 fusion proteins, or upregulation of miR-17, on KIT-induced proliferation and myeloid differentiation, and 2) the effect of upregulation of KIT-induced proliferation per se on myeloid cell differentiation. Results In the first part of this study we found that stable miR-17 upregulation affects, like the CBF-AML fusion proteins (RUNX1-MTG8 or CBFB-MYH11), a core RUNX1-miRNA mechanism leading to KIT-induced proliferation of differentiation-arrested U937 myeloid cells. In the second part of the study we harnessed the conservation of this core mechanism in human and mouse to demonstrate that the extent of KIT upregulation in 32D mouse myeloid cells with wild type RUNX1 can per se delay G-CSF-induced differentiation. The integrated information gathered from the two myeloid cell models shows that RUNX1 regulates myeloid differentiation not only by direct transcriptional regulation of coding and non-coding myeloid differentiation functions (e.g. miR-223), but also by modulating KIT-induced proliferation via non-coding miRNAs (e.g. miR-221). Conclusions The novelty of this study is dual. On the one hand, miRNAs (e.g. miR-17) can mimic the effects of CBF-AML fusion proteins by affecting a core RUNX1-miRNA mechanism of KIT-induced proliferation of undifferentiated myeloid cells. On the other hand, the extent of KIT-induced proliferation itself can modulate myeloid differentiation of cells with wild type RUNX1 function.